News | September 06, 2025
Zydus Lifesciences gets 4 USFDA observations for Jarod Injectable facility
Zydus will work closely with the USFDA to address and resolve the observations in an expeditious manner
Zydus will work closely with the USFDA to address and resolve the observations in an expeditious manner
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
Saroglitazar was generally well tolerated, with overall adverse events generally balanced between Saroglitazar-treated and placebo-treated patients
The inspection concluded with NIL observations
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Diltiazem works by relaxing blood vessels, which reduces the workload on the heart and increases blood and oxygen supply to the heart muscle
Prucalopride is prescribed for chronic idiopathic constipation
This is the group’s first NoC approval in Canada
Subscribe To Our Newsletter & Stay Updated
